Learn more

SCHWEIZ SERUM & IMPFINST

Overview
  • Total Patents
    179
About

SCHWEIZ SERUM & IMPFINST has a total of 179 patent applications. Its first patent ever was published in 1915. It filed its patents most often in Canada, United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are EMERGEX VACCINES HOLDINGS LTD, EMERGEX VACCINES HOLDING LTD and SERUM INSTITUTE OF INDIA PRIVATE LTD.

Patent filings per year

Chart showing SCHWEIZ SERUM & IMPFINSTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cryz Stanley J 20
#2 Glueck Reinhard 17
#3 Gluck Reinhard 13
#4 Germanier Rene 9
#5 Favre Didier 9
#6 Viret Jean-Francois 9
#7 Collioud Andre 9
#8 Mischler Robert 7
#9 Fuerer Emil 6
#10 Billeter Martin A 6

Latest patents

Publication Filing date Title
US2003113347A1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
DE19851282A1 Composition of a pharmaceutically active substance, applied in a specific delivery system for the prevention and treatment of infectious diseases
WO9852603A2 An influenza enveloped dna vaccine
US6891037B1 Method for the isolation of polysaccharides
WO9714782A1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens
EP0780475A1 Process for the production of infectious negative-strand RNA viruses
US5549896A Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
US5879685A Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
HRP930279A2 Process for preparing living vaccine against mumps
AU1743692A New hepatitis A virus strain, method for the isolation of new hepatitis A virus strains and hepatitis A vaccines
WO9219267A1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
EP0564689A1 Recombinant live vaccines against Gram-negative enteric pathogens
EP0562132A1 Monoclonal anti-tetanus toxin antibodies and pharmaceutical compositions containing them
US5370872A Escherichia coliO-polysaccharide-protein conjugate vaccine
CA2035386A1 Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
US4935364A Method of isolating restriction fragment deletions in vibrio cholerae and products thereof
ZA8800792B Conjugate malaria vaccine
CA1329124C Conjugate malaria vaccine
AU7459987A DNA fragments encoding the chromosomal nucleotide sugar synthetases and glycosyltransferases involved in the biosynthesis of the o-antigen of shigella dysenteriae, recombinant DNA molecules containing said fragments, host organisms containing said recombinant DNA molecules vaccines for preventing bacillary dysentery and method for preventing bacillary dysentery
ZA8606843B Vaccine against mumps and process for its preparation